US Stock MarketDetailed Quotes
CTXRW Citius Pharmaceuticals Inc C/Wts 00/00/2022 (To Pur Com)
- 0.0000
- 0.00000.00%
Close Nov 22 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.144152wk High0.00P/B0Float Cap0.016052wk Low--Dividend TTM0Shs Float2.8900Historical High--Div YieldTTM0.00%Amplitude0.0122Historical Low--Avg Price1Lot Size
Citius Pharmaceuticals Inc C/Wts 00/00/2022 (To Pur Com) Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2022 | (Q2)Mar 31, 2022 | (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | (Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | (FY)Sep 30, 2020 | (Q4)Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -59.88%-7.71M | -126.28%-9.67M | 51.37%-4.65M | -43.23%-24.25M | -66.51%-5.59M | -20.86%-4.82M | 4.39%-4.27M | -87.02%-9.56M | -36.12%-16.93M | -15.50%-3.36M |
| Net income from continuing operations | -52.19%-8.86M | -83.41%-7.56M | -13.24%-9.23M | -31.38%-23.05M | -20.40%-4.96M | -24.44%-5.82M | 6.84%-4.12M | -88.48%-8.15M | -12.76%-17.55M | -12.90%-4.12M |
| Operating gains losses | ---- | ---- | ---- | ---166.56K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 8.79%45.35K | 9.55%44.47K | 9.50%43.61K | 8.21%164.87K | 9.31%42.77K | 34.31%41.68K | -14.46%40.59K | 14.61%39.82K | 16,962.04%152.36K | 20,823.53%39.13K |
| Other non cash items | --0 | --178K | --95.88K | -87.14%68K | --0 | --0 | ---- | ---- | 149.89%528.77K | 6.27%100K |
| Change In working capital | -82.47%102.57K | -457.55%-3.35M | 303.54%3.53M | -213.42%-2.72M | -358.36%-968.02K | 27.14%585.25K | -8.19%-600.42K | -51.18%-1.73M | -139.48%-866.97K | -26.72%374.68K |
| -Change in prepaid assets | -5,197.80%-287.21K | 225.84%20.44K | 119.08%217.85K | -3,407.72%-2.6M | -1,980.54%-1.47M | 170.61%5.63K | 201.20%6.27K | -14,855.93%-1.14M | -63.62%-74.13K | -20.61%-70.66K |
| -Change in payables and accrued expense | -119.86%-50.04K | -1,438.40%-1.88M | 488.22%3.03M | 77.35%-209.22K | 268.24%177.66K | -17.48%252.01K | 280.36%140.77K | 35.00%-779.65K | -175.65%-923.82K | -87.13%48.24K |
| -Change in other current liabilities | -11.56%-44.43K | -11.56%-43.56K | -11.56%-42.7K | -29.00%-159K | -11.56%-41.85K | -11.95%-39.83K | -11.95%-39.04K | -150.44%-38.27K | ---123.25K | ---37.52K |
| -Change in other working capital | 31.79%484.25K | -103.33%-1.44M | 45.08%327.69K | -1.24%251.08K | -15.74%366.19K | 94.99%367.44K | -59.52%-708.42K | 199.99%225.88K | 26.00%254.23K | 122.87%434.61K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -59.88%-7.71M | -126.28%-9.67M | 51.37%-4.65M | -43.23%-24.25M | -66.51%-5.59M | -20.86%-4.82M | 4.39%-4.27M | -87.02%-9.56M | -36.12%-16.93M | -15.50%-3.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,184,877.50%-40.01M | -40M | -1.83K | 0 | ||||||
| Net PPE purchase and sale | ---- | ---- | ---- | -278.92%-6.94K | --0 | ---- | ---- | ---- | ---1.83K | --0 |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---40M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | -2,184,877.50%-40.01M | ---40M | ---- | ---- | ---- | ---1.83K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 426.11%120.47M | 0 | 105.57%16.8M | 1,620.13%103.67M | 371.70%500 | 105.41%22.9M | 38.31%8.7M |
| Net issuance payments of debt | ---- | ---- | ---- | -205.10%-172.97K | --0 | ---- | ---- | ---- | --164.58K | --0 |
| Net common stock issuance | --0 | --0 | --0 | 474.11%89.43M | --0 | --0 | --89.43M | --500 | 40.03%15.58M | 38.31%8.7M |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | 336.14%31.21M | --0 | 1,402.57%16.97M | ---- | ---- | 30,725.93%7.16M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | 426.11%120.47M | --0 | 105.57%16.8M | 1,620.13%103.67M | 371.70%500 | 105.41%22.9M | 38.31%8.7M |
| Net cash flow | ||||||||||
| Beginning cash position | -46.23%55.76M | 1,422.96%65.42M | 405.59%70.07M | 75.58%13.86M | 1,257.98%115.66M | 2,289.85%103.7M | 54.54%4.3M | 75.58%13.86M | -14.05%7.89M | 88.82%8.52M |
| Current changes in cash | -164.45%-7.71M | -109.72%-9.67M | 51.36%-4.65M | 842.23%56.21M | -953.38%-45.59M | 186.41%11.97M | 6,274.25%99.4M | -87.01%-9.56M | 562.40%5.97M | 57.92%5.34M |
| End cash Position | -58.46%48.04M | -46.23%55.76M | 1,422.96%65.42M | 405.59%70.07M | 405.59%70.07M | 1,257.98%115.66M | 2,289.85%103.7M | 54.54%4.3M | 75.58%13.86M | 75.58%13.86M |
| Free cash flow | -59.65%-7.71M | -126.28%-9.67M | 51.37%-4.65M | -279.49%-64.26M | -1,257.77%-45.59M | -20.98%-4.83M | 4.39%-4.27M | -87.02%-9.56M | -36.14%-16.93M | -15.50%-3.36M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data